Edition:
United Kingdom

Cancer Genetics Inc (CGIX.OQ)

CGIX.OQ on NASDAQ Stock Exchange Capital Market

0.23USD
5:21pm BST
Change (% chg)

$0.00 (+1.62%)
Prev Close
$0.23
Open
$0.22
Day's High
$0.23
Day's Low
$0.22
Volume
22,108
Avg. Vol
489,059
52-wk High
$1.29
52-wk Low
$0.20

Revenue & Earnings Per Share

    Revenue* Earnings Per Share**
FY 2018 Sep '18 5.94 -0.311
Jun '18 7.04 -0.134
Mar '18 7.67 -0.165
FY 2017 Dec '17 7.52 0.325
Sep '17 8.03 -0.029
Jun '17 6.60 -0.140
Mar '17 6.97 -0.507
 
*Note: Units in Millions ofU.S. Dollars
**Note: Units in U.S. Dollars

Consensus Estimates Analysis

  # of Estimates Mean High Low 1 Year Ago
SALES (in millions)
Quarter Ending Jun-19 1 11.24 11.24 11.24 11.24
Quarter Ending Sep-19 1 12.17 12.17 12.17 12.17
Year Ending Dec-19 1 46.82 46.82 46.82 47.03
Year Ending Dec-20 1 54.25 54.25 54.25 60.92
Earnings (per share)
Year Ending Dec-19 1 -0.30 -0.30 -0.30 -0.29
Year Ending Dec-20 1 -0.06 -0.06 -0.06 -0.07
Sales and Profit Figures in US Dollar (USD);

Valuation Ratios

  Company industry sector
P/E Ratio (TTM) -- 27.13 62.94
P/E High - Last 5 Yrs. -- 122.58 56.44
P/E Low - Last 5 Yrs. -- 24.93 28.76
Beta 1.19 0.50 0.93
Price to Sales (TTM) 0.46 7.59 9.69
Price to Book (MRQ) 0.69 3.38 4.53
Price to Tangible Book (MRQ) -- 5.64 8.07
Price to Cash Flow (TTM) -- 16.45 43.55
% Owned Institutions -- 0.00 0.00

Dividends

  Company industry sector
Dividend Yield -- 1.06 1.54
Dividend Yield - 5 Year Avg -- 0.81 0.70
Dividend 5 Year Growth Rate -- 5.21 2.98
Payout Ratio(TTM) -- 30.03 21.89

Growth Rates

  Company industry sector
Sales (MRQ) vs Qtr. 1 Yr. Ago -26.01 20.23 9.11
Sales (TTM) vs TTM 1 Yr. Ago -2.30 8.34 8.34
Sales - 5 Yr. Growth Rate 46.59 11.95 11.19
EPS (MRQ) vs Qtr. 1 Yr. Ago -960.84 -18.61 112.52
EPS (TTM) vs TTM 1 Yr. Ago 65.37 -- --
EPS - 5 Yr. Growth Rate -- 5.09 6.94
Capital Spending - 5 Yr. Growth Rate 36.48 5.76 7.63

Financial Strength

  Company industry sector
Quick Ratio (MRQ) -- 5.19 2.67
Current Ratio (MRQ) 0.46 5.44 3.63
LT Debt to Equity (MRQ) 4.88 36.06 13.38
Total Debt to Equity (MRQ) 128.04 46.70 17.12
Interest Coverage (TTM) -3.15 29.61 27.35

Profitability Ratios

  Company industry sector
Gross Margin (TTM) 29.60 37.17 50.33
Gross Margin - 5 Yr. Avg. 31.17 40.58 50.77
EBITD Margin (TTM) -82.55 -- --
EBITD - 5 Yr. Avg -84.63 10.30 15.75
Operating Margin (TTM) -98.40 6.56 -2.12
Operating Margin - 5 Yr. Avg. -92.72 4.21 11.07
Pre-Tax Margin (TTM) -90.95 6.11 -2.97
Pre-Tax Margin - 5 Yr. Avg. -101.25 6.04 16.81
Net Profit Margin (TTM) -33.03 3.40 -6.92
Net Profit Margin - 5 Yr. Avg. -77.65 3.50 11.75
Effective Tax Rate (TTM) -- 23.44 22.89
Effective Tax Rate - 5 Yr. Avg. -- 36.11 23.86

Efficiency

  Company industry sector
Revenue/Employee (TTM) 129,202 5,459,665 767,389,378
Net Income/Employee (TTM) -42,679 -387,962 88,365,779
Receivable Turnover (TTM) 2.27 6.66 5.22
Inventory Turnover (TTM) -- 77.69 3.64
Asset Turnover (TTM) 0.60 0.56 0.80

Management Effectiveness

  Company industry sector
Return on Assets (TTM) -19.83 4.45 9.51
Return on Assets - 5 Yr. Avg. -31.53 6.00 10.45
Return on Investment (TTM) -34.57 5.75 11.75
Return on Investment - 5 Yr. Avg. -40.49 7.61 13.34
Return on Equity (TTM) -46.08 -9.55 12.58
Return on Equity - 5 Yr. Avg. -50.47 10.64 14.82
  1 Year 3 Year 5 Year
Sales % 7.66 41.87 46.59
EPS (TTM) % 72.43 -- --
Dividend % -- -- --
Note: Units in Millions of US Dollars

Performance for Cancer Genetics Inc

Period %
Actual
% vs.
S&P 500
Rank In
Industry
Industry
Rank
4 Week -11.82 -15.14 13 35
13 Week -19.05 -25.65 17 55
26 Week -73.67 -75.04 3 28
52 Week -79.17 -80.88 4 55
YTD -5.33 -18.39 31 29
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.

Institutional Holders

% Shares Owned: 10.11%
# of Holders: 33
Total Shares Held: 5,691,926
3 Mo. Net Change: 3,222,599
# New Positions: 3
# Closed Positions: 0
# Increased Positions: 3
# Reduced Positions: 2
# Net Buyers: 1
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.